Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia
Clinical trial NCT01854918 · COMPLETED
Trial details
- NCT number
- NCT01854918
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-23
- Primary completion
- 2018-05-31
- Enrollment
- 3681
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.